| 2024/04/16 10:08:20 15 minutes delayed | |
|---|---|
| Price | |
| 2.54 HKD | |
| Difference | -5.22% (-0.14) |
General attributes
| ISIN | KYG8167W1380 |
| Symbol | 1177 |
| Exchange | Hong Kong Stock Exchange |
| Currency | HKD |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 5,618 EUR |
| Benchmark | HANG SENG INDEX |
Market data
| Bid (Bid size) | - |
| Ask (Ask size) | - |
| Open | 2.62 HKD |
| High | 2.68 HKD |
| Low | 2.52 HKD |
| Close (prev. day) | 2.68 HKD |
| VWAP | 2.56174 HKD |
| Volume (pcs) | - |
| Trading volume | - |
| Number of trades | - |
| Last size | - |
Futures and Options
| Related Futures | - |
| Related Options | - |
PDF Downloads
| Company report: SINO BIOPHARMACEUTICAL LTD. |  |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Recent research
| Date | Headline | Download | |
| 2024/04/03 |
|
Global Equity Ratings |
|
| 2024/03/13 |
|
Global Equity Ratings |
|
| 2024/02/22 |
|
Global Equity Ratings |
|
| 2024/02/14 |
|
Global Equity Ratings |
|
| 2024/01/23 |
|
Global Equity Ratings |
|
| 2024/04/16 10:08:20 15 minutes delayed | |
|---|---|
| Price | |
| 2.54 HKD | |
| Difference | -5.22% (-0.14) |
General attributes
| ISIN | KYG8167W1380 |
| Symbol | 1177 |
| Exchange | Hong Kong Stock Exchange |
| Currency | HKD |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 5,618 EUR |
| Benchmark | HANG SENG INDEX |
Market data
| Bid (Bid size) | - |
| Ask (Ask size) | - |
| Open | 2.62 HKD |
| High | 2.68 HKD |
| Low | 2.52 HKD |
| Close (prev. day) | 2.68 HKD |
| VWAP | 2.56174 HKD |
| Volume (pcs) | - |
| Trading volume | - |
| Number of trades | - |
| Last size | - |
Performance and Risk
| 6m | 1Y | 3Y | |
| Perf (%) | -8.63% | -44.54% | -68.49% |
| Perf (abs.) | -0.24 | -2.04 | -5.52 |
| Beta | 1.32 | 2.78 | 1.11 |
| Volatility | 47.05 | 40.74 | 39.54 |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Price data
| Ø price 5 days | Ø volume 5 days (pcs.) | 2.72 HKD (-) |
| Ø price 30 days | Ø volume 30 days (pcs.) | 3.00 HKD (-) |
| Ø price 100 days | Ø volume 100 days (pcs.) | 3.17 HKD (-) |
| Ø price 250 days | Ø volume 250 days (pcs.) | 3.33 HKD (-) |
| YTD High | date | 3.49 HKD (2024/01/02) |
| YTD Low | date | 2.52 HKD (2024/04/16) |
| 52 Weeks High | date | 4.66 HKD (2023/04/17) |
| 52 Weeks Low | date | 2.52 HKD (2024/04/16) |
All listings for SINO BIOPHARMACEUTICAL LTD.
| Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
| BX Swiss | - | - | - | 0.00 | - |
| Berlin | 2024/04/16 | 08:08 | 0.3023 EUR | 0.00 | 1 |
| Duesseldorf | 2024/04/16 | 12:30 | 0.2941 EUR | 0.00 | 3 |
| FINRA other OTC Issues | 2024/04/12 | 17:54 | 0.3828 USD | 0.00 | 1 |
| Frankfurt | 2024/04/16 | 08:11 | 0.30 EUR | 0.00 | 1 |
| Hanover | 2024/04/16 | 08:00 | 0.3101 EUR | 0.00 | 1 |
| Hong Kong Stock Exchange | 2024/04/16 | 10:08 | 2.54 HKD | - | - |
| Munich | 2024/04/16 | 08:05 | 0.3145 EUR | 0.00 | 1 |
| Stuttgart | 2024/04/16 | 10:30 | 0.295 EUR | 0.00 | 2 |
| Tradegate | 2024/04/16 | 09:59 | 0.31 EUR | 0.03 | 10 |
Company Logo
Contact Details
| SINO BIOPHARMACEUTICAL LTD. |
| - - |
| Unit 09, 41st Floor, Office Tower, Convention Plaza - - Hong Kong |
| Telefon: +852-2802-9886 |
| Fax: +852-2880-0847 |
| E-mail: info@sino-biopharm.com |
PDF Downloads
| Company report: SINO BIOPHARMACEUTICAL LTD. | |
Company Profile
Sino Biopharmaceutical Ltd. is an investment holding company, which engages in the manufacture and sale of pharmaceutical products. It operates through the following business segments: Modernised Chinese Medicines and Chemical Medicines, Investment, and Others. The Modernised Chinese Medicines and Chemical Medicines segment comprises the manufacturing, selling, and distribution of modernized Chinese medicine products and western medicine products. The Investment segment offers long term investments. The Other segment includes a research and development sector, which provides services to third-parties; and related healthcare and hospital business. It also develops medicines for treating tumors, analgesia, diabetes, and respiratory system diseases. The company was founded by Ping Tse on February 2, 2000 and is headquartered in Hong Kong. |
Members of Management Board
| Li Yi | Chairman of Managing Board |
| Cheng Cheung Ling | Member of Executive Committee |
| Li Mingqin | Member of Executive Committee |
| Theresa Tse | Member of Executive Committee |
| Tian Zhoushan | Member of Executive Committee |
| Tse Hsin | Member of Executive Committee |
| Tse Ping | Member of Executive Committee |
| Tse, Eric | Member of Executive Committee |
| Wang Shanchun | Member of Executive Committee |
Board of directors
| Theresa Tse | Chairman of Supervisory Board |
| Kwok Tung Li | Member of Supervisory Board |
| Zheng Fei Lu | Member of Supervisory Board |
| Cheung Ling Cheng | Member of Supervisory Board |
| Da Kui Li | Member of Supervisory Board |
| Hong Lu | Member of Supervisory Board |
| Hsin Tse | Member of Supervisory Board |
| Lu Fu Zhang | Member of Supervisory Board |
| Ming Qin Li | Member of Supervisory Board |
| Ping Tse | Member of Supervisory Board |
| Zhou Shan Tian | Member of Supervisory Board |